Evonik, a member of Bio Nebraska, announced on May 25, 2023, that it will launch an updated version of Biolys®, a lysine source for livestock feeds. The company’s Blair, Neb. facility will be one of the two Evonik facilities producing the product. Read more
Kate Engel has been named interim executive director of the Nebraska Innovation Campus, a member of Bio Nebraska. Engel joined the NIC team in 2011 prior to its 2012 groundbreaking. Read more
Virtual Incision, a member of Bio Nebraska, announced that its MIRA Surgical System is under substantive review by the U.S. Food and Drug Administration (FDA) for use in bowel resection procedures. Read more
UNeMed, a member of Bio Nebraska, will again host its Technology Transfer Boot Camp, August 7-11, 2023. Applications are open through July 1, 2023. Read more
For our May Member Spotlight, we talked to Dryland Genetics, a crop breeding company focused on ensuring a sustainable food supply for a world with less water. Read more
UNMC hosted a ground-breaking event for Catalyst, a building that will bring UNMC’s UNeMed and UNeTech branches together to facilitate the growth of research and innovation and allow entrepreneurs, investors and innovators to collaborate. Read more
Thyreos, a member of Bio Nebraska, announced that it has closed a $1 million series seed b round of financing and has been awarded a $1.6 million Small Business Technology Transfer Fast-Track grant from the National Institutes of Health National Institute of Allergy and Infectious Diseases for the development of an HSV-2 vaccine. Read more
Rob Owen, Executive Director of Bio Nebraska, testified on May 3, 2023, at a public hearing on an EPA proposal to reduce the amount of ethylene oxide that comes out of commercial sterilizers. Read more
Renewable Fuels Month highlights the importance of renewable biofuels, such as ethanol and biodiesel, especially for Nebraskans. Read more
Bristol Myers Squibb, a member of Bio Nebraska, announced that TRANSCEND FL and TRANSCEND NHL 001 studies of Breyanzi (lisocabtagene maraleucel) in relapsed or refractory follicular lymphoma and mantle cell lymphoma meet primary endpoint of overall response rate. Read more